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ceptable systemic systolic pressure, for example, P min 
=60 mm Hg. On the basis of equation 1, it is dear that 
for a sufficiently dilated ventricle 
R> (2) 
It follows that stroke volume approach es zero! In this 
limiting case, resection of ventricular mass, by reducing R 
while keeping h constant, will obviously increase stroke 
volume to a non-zero value. In fact, if ventricular dysfunc-
tion were occurring purelyon a geometric basis (due to 
dilatation with normal intrinsic fiber contractility), an 
appropriate ventricular resection such that R/h were 
corrected to normal, would lead to areturn to normal 
function! 
These examples demonstrate that the analysis of 
Chanda, Kuribayashi, and Abe2 is overly optimistic and 
the analysis of Dickstein and coworkers l is overly 
pessimistic about the potential beneficial effects of the 
Batista procedure. There are extreme theoretical cases 
in which the Batista procedure dearly will lead to an 
increase in function in absolute terms. There are other 
extremes in which function will be worsened. In both 
cases stress will be reduced. Therefore stress reduction 
alone does not imply any particular acute effect on 
function. A more careful analysis is needed that exam-
ines the set of circumstances in between these two 
extremes. An appropriate theory should allow for a 
quantitative prediction of when and whether a benefi-
cial effect of the Batista procedure should be expected. 
Charles R. Bridges, MD, ScD 
Department 01 Surgery 
Hospital 01 the University 01 Pennsylvania 
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Reply to the Editor: 
It is our great pleasure to address the points raised by 
Bridges in his letter regarding our recently published 
letter. l McCarthy and associates2 have dearly described 
the indication for the Batista procedure in patients with 
dilated cardiomyopathy. Bridges has quoted the opposite 
(" ... reduction of ventricular mass leads to a reduction in 
calculated systolic stress") of what we intended to say in 
our letter: The basic principle of the Batista operation for 
dilated cardiomyopathy is not to reduce the mass of the 
ventride but to reduce the volume 01 the chamber of the 
dilated ventride, and thus to reduce the wall stress of the 
ventricle. This was our only criticism of the comment 
made by Dickstein, Spotnitz, and Burkhoff3 in their arti-
de. This was evidenced in examples 1 applying equation 7 
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cited in the text by Dickstein and colleagues? Our thanks 
to Bridges for correcting the erroneous unit of the calcu-
lated wall stress (kdyne/cm2 instead of dyne/cm2), which 
was inadvertently overlooked. Although the judgment of 
"optimism" and "pessimism" goes beyond "hand waving," 
one should take into the account that the expected 
survival after transplantation would be only 5% over the 
subsequent year for patients waiting 6 months, wh ich is 
the waiting time for many outpatients.4 
In our letter l we have discussed the import an ce of left 
ventricular mass/left ventricular end-systolic volume 
(L VM/LVESV) ratio and left ventricular mass/left ven-
tricular end-diastolic volume (LVM/LVEDV) ratio on 
prognosis of survivals of patients with dilated cardiomy-
opathy. The survival was significantly high er for patients 
with an L VM/L VEDV ratio greater than 0.90 as com-
pared with those with an L VM/L VEDV ratio less than 
0.90.5 The calculated value of mean LVM/LVESV ratio in 
survivors and nonsurvivors with dilated cardiomyopathl 
was 1.36 and 1.06, respectively.1 Similarly, in another 
report in patients with compensated dilated cardiomyop-
athy,1 the calculated me an L VM/L VESV ratio (1.8) was 
higher than that (1.09) in patients with decompensated 
dilated cardiomyopathy. 1 
On the basis of our present and previous discus-
sion, I. H, ') we speculate that patients with end-stage dilated 
cardiomyopathy with L VM/L VESV and L VM/L VEDV 
ratios less than 1.3 and 0.9, respectively, would be candi-
dates for ventricular chamber volume reduction; intracav-
ity patch-employed partial ventriculectomy and muscle-
sparing chamber volume reduction would be the strategies 
when myocardial thickness is more (or equal to) and less 
than 10 mm, respectively. 
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Reply to the Editor: 
Several clinical studies are underway to test the efficacy 
of ventricular resection surgery as a therapy for patients 
with dilated cardiomyopathy. While the community awaits 
the results of these clinical studies, several investigators 
have applied mathematical modeling to more rigorously 
test the theoretical basis for this procedure. However, the 
results from a given model may be inftuenced not only by 
the fundamental assumptions of the model but also by the 
particular set of parameters chosen for the model. Con-
fticting results and complexities of the models lead to 
confusion among clinicians as to the value of modeling. 
The role of ventricular resection for the treatment of 
dilated cardiomyopathy cannot be determined by theoret-
ical analyses, no matter how sophisticated or apparently 
realistic the model. The efficacy of this procedure will only 
be determined through intelligent clinical study design 
and proper interpretation of the resultant clinical data. lt 
should be recognized that the utility of modeling is to 
expose physiologic principles that are otherwise masked 
by the complexities of cardiovascular interactions. Models 
are particularly useful when there is a lack of available 
techniques to make the necessary measurements in pa-
tients. These principles aid in interpreting clinical data 
and sometimes in helping optimize certain aspects of the 
therapy. 
The fundamental principles revealed by our modell are 
as folIows: Ventricular resection results in increased end-
systolic elastance (apparent increase in chamber contrac-
tility), but also in increased diastolic stiffness. These 
offsetting effects on systolic and diastolic properties result 
in little change (we aetually prediet a slight deerease) in 
stroke volume at a given filling pressure (i.e., the Starling 
relationship is slightly depressed). Ejection fraction is 
increased primarily because of the decrease in end-dia-
stolic volume, not because of an increase in stroke vol-
urne; therefore, this increase in ejection fraction should 
not be interpreted as an increase in chamber contractility. 
Wall stress is decreased at a given peak ventricular 
pressure, but the significance of this is uncertain. Accord-
ingly, the success of the procedure (based on hemody-
namic criteria) should not be judged by indirect measures 
of chamber eontractility (such as ejection ffaction); func-
tional measures such as the Starling relationship or max-
imum oxygen eonsumption are more appropriate. 
The limited available data are already eonfirming these 
prineiples. Early clinieal studies revealed little change in 
stroke volume as a result of the operation? More recently, 
Kawaguehi and as~ociates' measured pressure-volumc 
relations in patients before and after reduction surgery 
and confirmed our predictions, inc1uding apostoperative 
reduction in stroke volume despite an increase in end-
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systolie elastance and cjection fraction. Finally, in a study 
of four patients, Goresan and eolleagues4 found a marked 
increase in diastolie stiffness as measured by end-diastolic 
pressure-area relations. 
It is basically irrelevant whether or not the predictions 
of our model agree with those of another model. What is 
relevant is whether validity of the fundamental prineiples 
deduced from the model is con.firmed by results of c1inieal 
studies. In this regard, available data support our predic-
tions. 
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Pleural tenting for upper lobectomy 
To the Editor: 
12/8/90659 
Robinson and Preksto I showed that obliterating the 
apical space with a pleural tent shortened the duration of 
air leaks after upper lobeetomies. This in turn resulted in 
redueed ehest tube time and length of hospital stay. I have 
not noticed a significant difference in air leaks when 
comparing upper lobectomies with lower lobeetomies in 
my patient population. To establish whether any addi-
tional maneuver, such as pleural tenting, would be bene-
ficial to my patients, I examined data from the last 20 
consecutive patients in whom I performed upper lobe 
reseetions. These patients are part of an ongoing clinical 
pathway study group. For age and gender distribution, 
type of operation, ehest tube time, and length of hospital 
stay, see Table I. No mortality and no significant morbid-
ity were recorded, the mean length of hospital stay was 1.5 
days, and only one of these patients had to be readmit-
ted-a patient with severe emphysema who had a sudden 
episode of shortness of breath 1 week after the ehest tube 
had been removed. A small anterior ehest tube was 
imcrtcd for ä pneumothorax, and the patient was dis-
eharged the day after the re admission and had no further 
complications. Another patient had temporary vocal cord 
dysfunetion resulting from manipulation of the left reeur-
